Voyager Therapeutics (VYGR) Retained Earnings (2014 - 2026)
Voyager Therapeutics (VYGR) reported Retained Earnings of -$263000.0 for Q1 2026, down 32.16% on a YoY basis from -$387681.5 in Q1 2025, and up 99.94% sequentially from -$445.9 million in Q4 2025.
Voyager Therapeutics (VYGR) Retained Earnings (2014 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 13 years of Retained Earnings data on file, last reported at -$263000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 32.16% year-over-year to -$263000.0; the trailing twelve-month figure through Mar 2026 stood at -$263000.0 (down 32.16% YoY), and the FY2025 full-year result was -$445.9 million, down 171.2% from the prior year.
- Retained Earnings advanced to -$263000.0 in Q1 2026, from -$445.9 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $634.7 million in Q2 2025 to a low of -$445.9 million in Q4 2025.
- A 5-year average of $2.0 million and a median of -$263000.0 in 2026 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings jumped 328152.9% in 2022 and tumbled 1268018.18% in 2025, its largest moves.
- Tracing VYGR's Retained Earnings over 5 years: stood at $452.7 million in 2022, then tumbled by 157.69% to -$261.2 million in 2023, then jumped by 339.79% to $626.3 million in 2024, then plunged by 171.2% to -$445.9 million in 2025, then surged by 99.94% to -$263000.0 in 2026.
- Business Quant data shows VYGR's Retained Earnings at -$263000.0 in Q1 2026, -$445.9 million in Q4 2025, and -$418.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - | -263,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -263,000.00 |
| Dec 31, 2025 | -445.91 Mn |
| Sep 30, 2025 | -418.48 Mn |
| Jun 30, 2025 | 634.70 Mn |
| Mar 31, 2025 | -199,000.00 |
| Dec 31, 2024 | 626.30 Mn |
| Sep 30, 2024 | -33,000.00 |
| Jun 30, 2024 | -282.70 Mn |
| Mar 31, 2024 | -506,000.00 |
| Dec 31, 2023 | -261.18 Mn |
| Sep 30, 2023 | -248,000.00 |
| Jun 30, 2023 | -133,000.00 |
| Mar 31, 2023 | 486.52 Mn |
| Dec 31, 2022 | 452.71 Mn |
| Sep 30, 2022 | -337,000.00 |
| Jun 30, 2022 | -387.50 Mn |
| Mar 31, 2022 | -368.42 Mn |
| Dec 31, 2021 | -138,000.00 |
| Sep 30, 2021 | 440.33 Mn |
| Jun 30, 2021 | 438.30 Mn |